Health Library

Aarskog syndrome

Aarskog disease; Aarskog-Scott syndrome; AAS; Faciodigitogenital syndrome; Gaciogenital dysplasia

Aarskog syndrome is a very rare disease that affects a person's height, muscles, skeleton, genitals, and appearance. It can be passed down through families (inherited).

Images

I Would Like to Learn About:

Causes

Aarskog syndrome is a genetic disorder that is linked to the X chromosome. It affects mainly males, but females may have a milder form. The condition is caused by changes in a gene called faciogenital dysplasia (FGD1).

Symptoms

Symptoms of this condition include:

• Belly button that sticks out
• Bulge in the groin or scrotum
• Delayed sexual maturity
• Delayed teeth
• Downward palpebral slant to eyes (palpebral slant is the direction of the slant from the inner to outer corner of the eye)
• Hairline with a "widow's peak"
• Mildly sunken chest (pectus excavatum)
• Mild to moderate cognitive problems
• Mild to moderate short height, which may not be obvious until the child is 1 to 3 years old
• Poorly developed middle section of the face
• Rounded face
• Scrotum surrounds the penis (shawl scrotum)
• Short fingers and toes with mild webbing
• Single crease in the palm of the hand
• Small, broad hands and feet with short fingers and curved-in fifth finger
• Small nose with nostrils tipped forward
• Testicles that have not come down (undescended)
• Top portion of the ear folded over slightly
• Wide groove above the upper lip, crease below the lower lip
• Wide-set eyes with droopy eyelids

Exams and Tests

These tests may be done:

• Genetic testing for mutations in the FGD1 gene
• X-rays

Treatment

The treatment of Aarskog syndrome focuses on treating the symptoms which may vary among individuals. Eye, dental and hearing treatments may be needed. Sometimes surgery is needed to treat structural or functional malformations. Growth hormone treatment may improve height in some children.

Support Groups

More information and support for people with Aarskog syndrome and their families can be found at:

• National Organization for Rare Disorders -- rarediseases.org/rare-diseases/aarskog-syndrome
• NIH Genetic and Rare Diseases Information Center -- rarediseases.info.nih.gov/diseases/4775/aarskog-syndrome

Outlook (Prognosis)

Some people may have some mental slowness, but children with this condition often have good social skills. Some males may have problems with fertility.

Possible Complications

These complications can occur:

• Changes in the brain
• Difficulty growing in the first year of life
• Poorly aligned teeth
• Seizures
• Undescended testicles

When to Contact a Medical Professional

Contact your child's health care provider if your child has delayed growth or if you notice any symptoms of Aarskog syndrome. Seek genetic counseling if you have a family history of Aarskog syndrome. Contact a genetic specialist if your provider thinks you or your child may have Aarskog syndrome.

Prevention

Genetic testing may be available for people with a family history of the condition or a known gene alteration that causes it.

Related Information

References

D'Cunha Burkardt D, Graham JM. Abnormal body size and proportion. In: Pyeritz RE, Korf BR, Grody WW, eds. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics: Clinical Principles and Applications. 7th ed. Cambridge, MA: Elsevier Academic Press; 2019:chap 4.

Haddad J. Congenital malformations of the ear. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 678.

Jones KL, Jones MC, del Campo M. Moderate short stature, facial, ± genital. In: Jones KL, Jones MC, del Campo M, eds. Smith's Recognizable Patterns of Human Malformation. 8th ed. Philadelphia, PA: Elsevier; 2022:134-173.

Review Date: 10/27/2025  

Reviewed By: Anna C. Edens Hurst, MD, MS, Associate Professor in Medical Genetics, The University of Alabama at Birmingham, Birmingham, AL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

© 1997- 2026 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.